Citius Oncology Insider Trades
NASDAQ: CTORHealth CareBiotechnology: Pharmaceutical PreparationsUSD
Market open · Delayed 15 min · as of Oct 8, 10:01 AM ET
Last 12 months
- Purchases
- 0 · $0
- Sales
- 0 · $0
- Shares bought / sold
- 0 / 0
- Net activity
- Net buying $0
Citius Oncology insider activity
No Citius Oncology insider transactions were reported in the last 12 months; the table shows the most recent historical filings. The most recent filing shows Webb Carol (Director) reporting a transaction in 300,000 shares on Sep 19, 2025. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CTOR's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
CTOR insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 19, 2025 | Holuka Eugene MyronDirector | Award | 300,000 | — | Form 4 |
| Sep 19, 2025 | Dutia Suren GDirector | Award | 300,000 | — | Form 4 |
| Sep 19, 2025 | Mayersohn Joel DavidDirector | Award | 300,000 | — | Form 4 |
| Sep 19, 2025 | MCGRATH DENNIS MDirector | Award | 300,000 | — | Form 4 |
| Sep 19, 2025 | Webb CarolDirector | Award | 300,000 | — | Form 4 |
| Sep 19, 2025 | Bartushak JaimeChief Financial Officer | Award | 825,000 | — | Form 4 |
| Sep 19, 2025 | Mazur Leonard LChief Executive Officer | Award | 1,700,000 | — | Form 4 |
| Sep 19, 2025 | Czuczman MyronChief Medical Officer | Award | 825,000 | — | Form 4 |
| Sep 19, 2025 | Smith Robert JosephDirector | Award | 300,000 | — | Form 4 |
| Sep 19, 2025 | HOLUBIAK MYRON ZSecretary | Award | 100,000 | — | Form 4 |
| Sep 19, 2025 | HOLUBIAK MYRON ZSecretary | Award | 850,000 | — | Form 4 |
| Sep 19, 2025 | Czuczman MyronChief Medical Officer | Award | 825,000 | — | Form 4 |
| Sep 19, 2025 | Dutia Suren GDirector | Award | 300,000 | — | Form 4 |
| Sep 19, 2025 | Smith Robert JosephDirector | Award | 300,000 | — | Form 4 |
| Sep 19, 2025 | MCGRATH DENNIS MDirector | Award | 300,000 | — | Form 4 |
| Sep 19, 2025 | Mazur Leonard LChief Executive Officer | Award | 1,700,000 | — | Form 4 |
| Sep 19, 2025 | Webb CarolDirector | Award | 300,000 | — | Form 4 |
| Sep 19, 2025 | Mayersohn Joel DavidDirector | Award | 300,000 | — | Form 4 |
| Sep 19, 2025 | HOLUBIAK MYRON ZSecretary | Award | 850,000 | — | Form 4 |
| Sep 19, 2025 | Bartushak JaimeChief Financial Officer | Award | 825,000 | — | Form 4 |
| Sep 19, 2025 | Holuka Eugene MyronDirector | Award | 300,000 | — | Form 4 |
| Sep 19, 2025 | Dutia Suren GDirector | Award | 300,000 | — | Form 4 |
| Sep 19, 2025 | Mayersohn Joel DavidDirector | Award | 300,000 | — | Form 4 |
| Sep 19, 2025 | MCGRATH DENNIS MDirector | Award | 300,000 | — | Form 4 |
| Sep 19, 2025 | Holuka Eugene MyronDirector | Award | 300,000 | — | Form 4 |
| Sep 19, 2025 | Mazur Leonard LChief Executive Officer | Award | 1,700,000 | — | Form 4 |
| Sep 19, 2025 | Bartushak JaimeChief Financial Officer | Award | 825,000 | — | Form 4 |
| Sep 19, 2025 | Czuczman MyronChief Medical Officer | Award | 825,000 | — | Form 4 |
| Sep 19, 2025 | Smith Robert JosephDirector | Award | 300,000 | — | Form 4 |
| Sep 19, 2025 | HOLUBIAK MYRON ZSecretary | Award | 850,000 | — | Form 4 |
| Sep 19, 2025 | Webb CarolDirector | Award | 300,000 | — | Form 4 |
| Jul 28, 2025 | Mayersohn Joel DavidDirector | other | 21,228 | — | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4